AMIT GUPTA
*********@*****.*** • 408-***-**** • Sunnyvale, CA 94087
linkedin.com/in/amitgupta1988
EDUCATION
Master of Science in Regulatory Affairs
Long Island University, Brooklyn, NY, May 2015
Bachelor of Pharmacy
Mumbai University, Mumbai, India, May 2011
SUMMARY
2.5 Years of combined experience in Drug Safety Reporting and Regulatory Affairs
Prepared and assisted Regulatory Submission. Drafted templates for regulatory submission and arranged meetings for the regulatory team as per everyone availability
Ability to prepare INDs, Annual Reports and AE Reports. Knowledge of FDA approval process, Trial Master File (TMF), Informed Consent Form, 1572 Form, IRB Submission, NDA, ICH, cGMP
Knowledge of Clinical Trial Start up and Close-Out Visits, Structured Product Labeling (SPL), Amendments and Supplements, Requirements on Pharmaceutical Labeling and Drug Advertisement, Enforcement Actions like 483s, Warning letter and Recall
PROFESSIONAL EXPERIENCE
Duke Translational Medicine Institute Regulatory Affairs Remote Internship Jan 2015 - Feb 2015
Received training on IND Submission and Pre-IND Meeting Briefing Packets
Gained knowledge of IND exempt submissions request
Utilized knowledge of 21 CFR part 50, 56, 211, 312 and GCP guidelines
Pharmacyclics, Sunnyvale, CA Regulatory Safety Intern (Oncology) Jun 2014 - Aug 2014
Prepared narrative template for clinical safety and efficacy narratives
Reviewed source documents (e.g. tables, figures, listings, narrative event trackers, individual case subject reports) and wrote clinical safety and efficacy narratives for registrational study in Waldenstrom’s Macroglobulinemia and for a phase 2 study in Diffuse Large B-cell Lymphoma
Worked with cross-functional teams with Biostatistics and Clinical Operation for completion and comparison of data cleaning and source documents
Presented presentation to the Regulatory team on Breakthrough Therapy Approval Process in USA
Cognizant /Novartis, Mumbai, India Drug Safety Associate Jun 2011 - Aug 2013
Performed triage, initial checks, search database to prevent duplicate entries, created case file and initialize received drug safety reports in the Argus safety database
Wrote, edited or summarized of Individual Case Safety Reports (ICSR) including spontaneous case reporting, Medical/Scientific literature cases, PMS study reports in MedWatch
Coded adverse events (AE) utilizing MedDRA including clinical narrative writing in accordance with company standard operating procedures (SOPs)
Managed and identified clinically relevant information missing from case report and facilitate its collection (in consultation with medical staff as required) by preparing follow-up requests as needed
Received quarterly honor award from global PV head for best quality deliverance
CLASS PROJECT
Long Island University, Brooklyn, NY Regulatory Project Manager Nov 2014 - Dec 2014
Prepared an IND for fictional drug Seniger
Drafted strategy on IND and pre-IND meeting
Responsible for writing Modules I and II along with compilation of other modules in CTD format
PRESENTATION
Delivered a presentation on Off-label use of drugs
Gave a presentation on Expedited Drug Development Pathways in US
Presented a presentation on REMS vs RMP
CERTIFICATIONS
Professional Certificate on Protecting Human Research Participants from National Institute of Health (NIH), Jan 2015
Professional Certificate on Introduction to FDA Human Drug Review & Approval Basics from FDA, Jan 2015
COMPUTER SKILLS
Proficient in Microsoft Word, Excel, Outlook and PowerPoint
Proficient in Adobe Acrobat, Argus, Lotus and SPSS software